AmacaThera is a Toronto-based biotechnology company focused on transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas. Grounded in the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is developing products at the intersection of biomaterials and pharmaceuticals.